Showing results (821-830 of 5,603) with videos related to
Sort By:
Pageof 561
Human Immunology|May 1, 2009
Melanoma vaccines: The problems of local immunosuppressionMarta E Polak, Nicola J Borthwick, Martine J Jager, et al.Human Immunology|May 1, 2009
Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonistsLuciano Adorini, Giuseppe PennaHuman Immunology|May 5, 2009
Polymorphisms of CXCR3-binding chemokines in type 1 diabetesPatrick Brück, Wiebke Bartsch, Marissa Penna-Martinez, et al.Human Immunology|May 6, 2009
Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesisTomoyuki Shibata, Tomomitsu Tahara, Ichiro Hirata, et al.Human Immunology|June 1, 2010
Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese populationMasahito Katahira, Satoko Segawa, Harumi Maeda, et al.Human Immunology|May 25, 2010
Distributions of human leukocyte antigen-A, -B, and -DRB1 alleles and haplotypes based on 46,915 Taiwanese donorsMeng-Jiun Lai, Shu-Hui Wen, Ya-Hui Lin, et al.Human Immunology|July 1, 1990
Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 moleculesG Bismuth, H Gouy, R W Karr, et al.Human Immunology|September 28, 2006
Association of kidney transplant failure and antibodies against MICAKazuo Mizutani, Paul Terasaki, Jean Denis Bignon, et al.Human Immunology|September 28, 2006
Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastasesGeert Koene, Arend Mulder, Kevin van der Ven, et al.Human Immunology|September 28, 2006
NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complicationsMarianna Romzova, Daniela Hohenadel, Katarina Kolostova, et al.Pageof 561